Comparative effectiveness of mRNA-1273 and BNT162b2 COVID-19 vaccines in immunocompromised individuals: a systematic review and meta-analysis using the GRADE framework

IntroductionDespite representing only 3% of the US population, immunocompromised (IC) individuals account for nearly half of the COVID-19 breakthrough hospitalizations. IC individuals generate a lower immune response after vaccination in general, and the US CDC recommended a third dose of either mRN...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Xuan Wang, Katrin Haeussler, Anne Spellman, Leslie E. Phillips, Allison Ramiller, Mary T. Bausch-Jurken, Pawana Sharma, Anna Krivelyova, Sonam Vats, Nicolas Van de Velde
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2023-09-01
coleção:	Frontiers in Immunology
Assuntos:	severe acute respiratory syndrome coronavirus 2 SARS-CoV-2 COVID-19 mRNA vaccine mRNA-1273 BNT162b2
Acesso em linha:	https://www.frontiersin.org/articles/10.3389/fimmu.2023.1204831/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!